U.S. Capital Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$620K Sell
7,156
-452
-6% -$39.6K 0.02% 630
2025
Q4
$645K Buy
7,608
+204
+3% +$16.3K 0.02% 593
2025
Q3
$537K Buy
7,404
+736
+11% +$50.8K 0.01% 620
2025
Q2
$437K Buy
6,668
+1,296
+24% +$84.4K 0.01% 626
2025
Q1
$379K Hold
5,372
0.01% 642
2024
Q4
$353K Sell
5,372
-567
-10% -$39K 0.01% 643
2024
Q3
$419K Buy
5,939
+2,342
+65% +$163K 0.01% 517
2024
Q2
$239K Hold
3,597
0.01% 614
2024
Q1
$244K Sell
3,597
-675
-16% -$44.6K 0.01% 606
2023
Q4
$264K Buy
4,272
+675
+19% +$39.7K 0.01% 579
2023
Q3
$212K Hold
3,597
0.01% 586
2023
Q2
$215K Hold
3,597
0.01% 613
2023
Q1
$210K Hold
3,597
0.01% 601
2022
Q4
$223K Hold
3,597
0.01% 581
2022
Q3
$203K Hold
3,597
0.01% 592
2022
Q2
$230K Buy
+3,597
New +$228K 0.01% 605

Other funds holding IHE